BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
SIRT1
,
Apoptosis
,
Pseudomonas infection
,
Heart
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hIL 2
Summary
General Info
Curated Studies
Most Correlated Studies
Regulatory T cells (CD4+ THY1.1+) with tamoxifen-induced E47 expression
CD4+ T helper Th1 cells, T-bet+ from Tbx21 knockout or wildtype mice
Monocytes from PBMCs of healthy donors treated with SARS-CoV-2 mimic of IL-17A ORF8 and IL-17A
Irradiated human fibroblasts compared to cells at each phase of cell cycle
Striatal cell gene expression regulated by TG2 in a transgenic model of Huntington disease (HD)
Explore Curated Studies Results
Literature
Most Relevant Literature
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that i…
Production of an active anti-CD20-hIL-2 immunocytokine in Nicotiana benthamiana.
Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin prom…
A BCR/ABL-hIL-2 DNA vaccine enhances the immune responses in BALB/c mice.
Transgenic tobacco plants as production platform for biologically active human interleukin 2 and its…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Su…
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors or DIPG
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma;…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ